157 related articles for article (PubMed ID: 30911657)
1. Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study.
Van De Sande L; Graversen M; Hubner M; Pocard M; Reymond M; Vaira M; Cosyns S; Willaert W; Ceelen W
Pleura Peritoneum; 2018 Jun; 3(2):20180112. PubMed ID: 30911657
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases.
Ceelen W; Sandra L; de Sande LV; Graversen M; Mortensen MB; Vermeulen A; Gasthuys E; Reynders D; Cosyns S; Hoorens A; Willaert W
EBioMedicine; 2022 Aug; 82():104151. PubMed ID: 35843174
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
[TBL] [Abstract][Full Text] [Related]
4. Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2.
Graversen M; Detlefsen S; Asmussen J; Mahdi B; Fristrup C; Pfeiffer P; Mortensen MB
Pleura Peritoneum; 2018 Jun; 3(2):20180108. PubMed ID: 30911656
[TBL] [Abstract][Full Text] [Related]
5. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.
Somashekhar SP; Ashwin KR; Rauthan CA; Rohit KC
Pleura Peritoneum; 2018 Sep; 3(3):20180110. PubMed ID: 30911661
[TBL] [Abstract][Full Text] [Related]
6. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO.
Oliver Goetze T; Al-Batran SE; Pabst U; Reymond M; Tempfer C; Bechstein WO; Bankstahl U; Gockel I; Königsrainer A; Kraus T; Mönig SP; Rau B; Schwarzbach M; Piso P
Pleura Peritoneum; 2018 Jun; 3(2):20180113. PubMed ID: 30911658
[TBL] [Abstract][Full Text] [Related]
7. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
Bakrin N; Tempfer C; Scambia G; De Simone M; Gabriel B; Grischke EM; Rau B
Pleura Peritoneum; 2018 Sep; 3(3):20180114. PubMed ID: 30911662
[TBL] [Abstract][Full Text] [Related]
8. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
Eveno C; Jouvin I; Pocard M
Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study.
Graversen M; Detlefsen S; Fristrup C; Pfeiffer P; Mortensen MB
Pleura Peritoneum; 2018 Jun; 3(2):20180107. PubMed ID: 30911655
[TBL] [Abstract][Full Text] [Related]
10. Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity.
Lang N; Diciola A; Labidi-Galy I; Ris F; Di Marco M; Mach N; Petignat P; Toso C; Undurraga M; Hubner M
BMJ Open; 2023 Jan; 13(1):e067691. PubMed ID: 36604127
[TBL] [Abstract][Full Text] [Related]
11. 10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis.
Di Giorgio A; Macrì A; Ferracci F; Robella M; Visaloco M; De Manzoni G; Sammartino P; Sommariva A; Biacchi D; Roviello F; Pastorino R; Pires Marafon D; Rotolo S; Casella F; Vaira M
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831468
[TBL] [Abstract][Full Text] [Related]
12. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial.
De Simone M; Vaira M; Argenziano M; Berchialla P; Pisacane A; Cinquegrana A; Cavalli R; Borsano A; Robella M
Biomedicines; 2020 Apr; 8(5):. PubMed ID: 32365877
[TBL] [Abstract][Full Text] [Related]
13. Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis.
Kim G; Tan HL; Chen E; Teo SC; Jang CJM; Ho J; Ang Y; Ngoi NYL; Chee CE; Lieske B; Shabbir A; Wang LZ; So JBY; Yong WP
Pleura Peritoneum; 2018 Sep; 3(3):20180118. PubMed ID: 30911663
[TBL] [Abstract][Full Text] [Related]
14. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin.
Rotolo S; Ferracci F; Santullo F; Lodoli C; Inzani F; Abatini C; Pacelli F; Di Giorgio A
Int J Surg Case Rep; 2020; 77S(Suppl):S75-S78. PubMed ID: 33191190
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
[TBL] [Abstract][Full Text] [Related]
16. Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases.
Ukegjini K; Putora PM; Guidi M; Süveg K; Cihoric N; Widmann B; Steffen T
Oncology; 2021; 99(9):601-610. PubMed ID: 34265774
[TBL] [Abstract][Full Text] [Related]
17. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
[TBL] [Abstract][Full Text] [Related]
18. Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review.
Oh S; Paik H; Park SJ; Lee EJ; Kim HS
Gland Surg; 2021 Mar; 10(3):1244-1251. PubMed ID: 33842271
[TBL] [Abstract][Full Text] [Related]
19. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer.
Tempfer C; Giger-Pabst U; Hilal Z; Dogan A; Rezniczek GA
Arch Gynecol Obstet; 2018 Aug; 298(2):243-257. PubMed ID: 29869089
[TBL] [Abstract][Full Text] [Related]
20. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
